Exact Mass: 294.0950778
Exact Mass Matches: 294.0950778
Found 187 metabolites which its exact mass value is equals to given mass value 294.0950778,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Tuliposide B
Tuliposide b is a member of the class of compounds known as hexoses. Hexoses are monosaccharides in which the sugar unit is a is a six-carbon containing moeity. Tuliposide b is soluble (in water) and a very weakly acidic compound (based on its pKa). Tuliposide b can be found in garden onion, which makes tuliposide b a potential biomarker for the consumption of this food product.
6-tuliposide B
A 6-O-acyl-D-glucose in which the 6-acyl group is specified as (3S)-3,4-dihydroxy-2-methylidenebutanoyl. A secondary metabolite with potent antibacterial activity, occurring specifically in tulip anthers.
Tyrphostin B42
C17H14N2O3 (294.10043740000003)
D000970 - Antineoplastic Agents > D020032 - Tyrphostins D004791 - Enzyme Inhibitors
Glyzarin
Glyzarin is found in herbs and spices. Glyzarin is a constituent of Glycyrrhiza glabra (licorice)
7-Acetoxy-2-methylisoflavone
7-Acetoxy-2-methylisoflavone is found in herbs and spices. 7-Acetoxy-2-methylisoflavone is isolated from Glycyrrhiza glabra (licorice
gamma-L-Glutamyl-L-methionine sulfoxide
gamma-L-Glutamyl-DL-methionine sulfoxide is found in nuts. gamma-L-Glutamyl-DL-methionine sulfoxide is isolated from the seeds of Fagus silvatica (beechnuts). Isolated from the seeds of mung bean (Vigna radiata) and black gram (Vigna mungo). gamma-L-Glutamyl-L-methionine sulfoxide is found in pulses.
Rosoxacin
C17H14N2O3 (294.10043740000003)
Rosoxacin is a quinolone derivative antibiotic for the treatment of bacterial infection of respiratory tract, urinary tract, GI, CNS and immuno compromised patients. Rosoxacin is known to be effective against penicillin resistant strains and is a single dose orally administered drug, which avoids all complications of parenteral administration seen with penicillin, especially anaphylactic shock. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D000890 - Anti-Infective Agents
3-Methoxy-2-(4-methylbenzoyl)-4H-1-benzopyran-4-one
3-Methoxy-2-(4-methylbenzoyl)-4H-1-benzopyran-4-one is found in fruits. 3-Methoxy-2-(4-methylbenzoyl)-4H-1-benzopyran-4-one is a constituent of the roots of Mangifera indica (mango)
Tyrphostin B42
C17H14N2O3 (294.10043740000003)
Lanceolatin C
Pongamol (Lanceolatin C) is potent α-glucosidase inhibitor (IC50=103.5 μM) and has free-radical (DPPH) scavenging,antihyperglycemic, and antihyperglycemic activities[1].
pongamol
Pongamol (Lanceolatin C) is potent α-glucosidase inhibitor (IC50=103.5 μM) and has free-radical (DPPH) scavenging,antihyperglycemic, and antihyperglycemic activities[1].
hydroxymethylenetanshinquinone
1,2-Methylendioxy-6-nitroso-6abeta-aporphan|1,2-methylenedioxy-6-nitroso-6abeta-aporphane|5H-benzo[g]-1,3-benzodioxolo[5,6,4]quinoline-6,7,7a,8-tetrahydro-7-nitroso-(7aR)|N-nitrosoanonaine
C17H14N2O3 (294.10043740000003)
9,10-Anthracenedione, 2-acetyl-1-hydroxy-3,6-dimethyl-
1,2-Dihydro-1,6-dimethyl-3,11-dioxanaphth[2,1-e]azulene-10,12-dione
1-Hydroxy-2-acetyl-3,7-dimethyl-9,10-anthraquinone
1,3-Propanedione, 1-(4-methoxy-5-benzofuranyl)-3-phenyl-
amabiose|beta-D-glucopyranosyl(1->5)beta-D-hemslofuranosyl(1->2)
3-O-beta-D-glucopyranosyl-2-deoxy-D-ribono-gamma-lactone
AG-490
C17H14N2O3 (294.10043740000003)
2-(2-hydroxyphenyl)-4-phenylbenzene-1,3,5-triol
C17H14N2O3_(3S,3R)-4-Methyl-3-phenylspiro[1,4-benzodiazepine-3,2-oxirane]-2,5(1H,4H)-dione
C17H14N2O3 (294.10043740000003)
(4R,5S or 4S,5R)-4-hydroxy-5-((?-D-glucopyranosyloxy)methyl)dihydrofuran-2(3H)-one
rosoxacin
C17H14N2O3 (294.10043740000003)
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D000890 - Anti-Infective Agents
g-L-Glutamyl-L-methionine sulfoxide
1-O-(3R,4-dihydroxy-2-methylene-butanoyl)-beta-D-glucopyranose
6-O-(3R,4-dihydroxy-2-methylene-butanoyl)-beta-D-glucopyranose
tert-butyl N-[(3S)-4-oxo-3,5-dihydro-2H-1,5-benzothiazepin-3-yl]carbamate
n,n-bis(2-hydroxyethyl)-4-phenylenediamine sulphate
5-(4-(Benzyloxy)phenyl)-1H-pyrazole-3-carboxylic acid
C17H14N2O3 (294.10043740000003)
N,N-Bis(2-hydroxyethyl)-p-phenylenediamine sulphate
1-[(4-NITROBENZYLOXY)CARBONYL]-PYRROLIDINE-2-CARBOXYLIC ACID
(2-FLUORO-PHENYLAMINO)-ACETICACIDHYDRAZIDE
C17H14N2O3 (294.10043740000003)
2-Amino-3-phthalimid-1-ylpropiophenone
C17H14N2O3 (294.10043740000003)
Bucloxic acid
C16H19ClO3 (294.10226539999996)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents
N-(3-amino-4-methylphenyl)-3-(trifluoromethyl)benzamide
4-amino-3-methyl-N-[3-(trifluoromethyl)phenyl]benzamide
6-(Dibutylamino)-1,3,5-triazine-2,4-dithiol·sodium
1-BENZYL-2-OXO-1,2-DIHYDRO-1,8-NAPHTHYRIDIN-4-YL ACETATE
C17H14N2O3 (294.10043740000003)
6-(3-(5-FLUORO-6-METHYLPYRIDIN-2-YL)-1H-PYRAZOL-4-YL)-[1,2,4]TRIAZOLO[1,5-A]PYRIDINE
4,4,4-trifluoro-3-hydroxy-3-(4-phenylphenyl)butan-2-one
(z)-3,4-dihydro-3-(2-(4-methoxyphenyl)-2-oxoethylidene)quinoxalin-2(1h)-one
C17H14N2O3 (294.10043740000003)
2-oxo-2-(5-phenylmethoxy-1H-indol-3-yl)acetamide
C17H14N2O3 (294.10043740000003)
2-(4-METHOXY-PHENYL)-5-PHENYL-2H-PYRAZOLE-3-CARBOXYLIC ACID
C17H14N2O3 (294.10043740000003)
1-(4-METHOXYPHENYL)-5-PHENYL-1H-PYRAZOLE-3-CARBOXYLIC ACID
C17H14N2O3 (294.10043740000003)
7-Nitrobenzoxadiazole-6-aminohexanoic acid
(6-BROMOHEXYLOXY)-TERT-BUTYLDIMETHYL-
C12H27BrOSi (294.10144319999995)
1H-Indole-3-carboxaldehyde,2-methyl-1-[(2-nitrophenyl)methyl]-(9CI)
C17H14N2O3 (294.10043740000003)
1H-Indole,3-(2-nitroethenyl)-5-(phenylmethoxy)-
C17H14N2O3 (294.10043740000003)
1H-Indole-3-carboxaldehyde,2-methyl-1-[(3-nitrophenyl)methyl]-(9CI)
C17H14N2O3 (294.10043740000003)
Phccc
C17H14N2O3 (294.10043740000003)
PHCCC is a Group I mGluR antagonist with an IC50 of 3 μM. PHCCC is a selective positive modulator of mGlu4 receptor. Antiparkinsonian effect[1][2].
N-(4,7-dimethoxy-3-methyl-1,3-benzothiazol-2-ylidene)butanamide
2-[(1-Acetyl-1H-indol-3-YL)amino]benzoic acid
C17H14N2O3 (294.10043740000003)
3-[3-(5-methylfuran-2-yl)-1-phenyl-1H-pyrazol-4-yl]prop-2-enoic acid
C17H14N2O3 (294.10043740000003)
7-Methoxy-2-phenylimino-1-benzopyran-3-carboxamide
C17H14N2O3 (294.10043740000003)
4-Chloro-6-(4-piperazin-1-YL-1H-pyrazol-5-YL)benzene-1,3-diol
(3S,4S,4aR,5R,6R,7R,7aS)-5,6-bis(hydroxymethyl)spiro[4a,6,7,7a-tetrahydro-3H-furo[2,3-b][1,4]dioxine-2,2-oxolane]-3,4,7-triol
(E/Z)-AG490
C17H14N2O3 (294.10043740000003)
4-Amino-5-(2-amino-4-methylsulfanylbutanoyl)peroxy-5-oxopentanoic acid
3-(9-carbazolylmethyl)-4-methyl-1H-1,2,4-triazole-5-thione
2-[(2,5-Dimethyl-3-phenyl-7-pyrazolo[1,5-a]pyrimidinyl)thio]acetonitrile
3-(4-Hydroxybenzyl)-6-[2-(methylsulfanyl)ethyl]-2,5-piperazinedione
(4R,5S)-4-hydroxy-5-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxolan-2-one
3-Methoxy-2-(4-methylbenzoyl)-4H-1-benzopyran-4-one
3-[5-carboxy-4-(carboxymethyl)pyrrolidin-3-yl]pyridine-2-carboxylic acid
(2r,3r,4s,5r)-2,3,4,5-tetrahydroxy-6-oxohexyl (3s)-3,4-dihydroxy-2-methylidenebutanoate
1,4-dihydroxy-2,5,5-trimethyl-9-thiatetracyclo[6.5.0.0²,¹¹.0³,⁷]tridec-3(7)-ene-6,12-dione
(12s)-7-methoxy-12-phenyl-5,13-dioxatricyclo[7.4.0.0²,⁶]trideca-1,3,6,8-tetraen-10-one
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (3s)-3,4-dihydroxy-2-methylidenebutanoate
(4r)-4-benzyl-4-methoxy-3,10-dioxatricyclo[7.3.0.0²,⁶]dodeca-1,6,8,11-tetraen-5-one
(?)-(2s)-6-methoxy-[2'',3'':7,8]-furanoflavanone
{"Ingredient_id": "HBIN006775","Ingredient_name": "(?)-(2s)-6-methoxy-[2'',3'':7,8]-furanoflavanone","Alias": "NA","Ingredient_formula": "C18H14O4","Ingredient_Smile": "COC1=C2C(=C3C(=C1)C(=O)CC(O3)C4=CC=CC=C4)C=CO2","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13927","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-β-hydroxymethylenetanshiquinone
{"Ingredient_id": "HBIN008250","Ingredient_name": "3-\u03b2-hydroxymethylenetanshiquinone","Alias": "NA","Ingredient_formula": "C18H14O4","Ingredient_Smile": "CC1=COC2=C1C(=O)C(=O)C3=C2C=CC4=C3CCC(C4=C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15888","TCMID_id": "10491","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-beta-Hydroxymethyllenetanshiquinone
{"Ingredient_id": "HBIN008251","Ingredient_name": "3-beta-Hydroxymethyllenetanshiquinone","Alias": "(7S)-7-hydroxy-1-methyl-6-methylene-8,9-dihydro-7H-naphtho[8,7-g]benzofuran-10,11-quinone; (7S)-7-hydroxy-1-methyl-6-methylidene-8,9-dihydro-7H-naphtho[8,7-g][1]benzoxole-10,11-dione; (7S)-7-hydroxy-1-methyl-6-methylene-8,9-dihydro-7H-naphtho[8,7-g]benzofuran-10,11-dione; 3-beta-hydroxymethyllenetanshiquinone","Ingredient_formula": "C18H14O4","Ingredient_Smile": "Not Available","Ingredient_weight": "294.32","OB_score": "32.16103376","CAS_id": "NA","SymMap_id": "SMIT00958","TCMID_id": "31235","TCMSP_id": "MOL007059","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
13,13,15-trimethyl-9,17-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-1,3,5,7,10,15-hexaene-12,14-dione
(1s,2r,4s,8s,11r)-1,4-dihydroxy-2,5,5-trimethyl-9-thiatetracyclo[6.5.0.0²,¹¹.0³,⁷]tridec-3(7)-ene-6,12-dione
(1r,13r)-17-methoxy-7,11,20-trioxapentacyclo[11.7.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]icosa-2(10),3,5,8,14,16,18-heptaene
5-(hydroxymethyl)-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxolan-2-one
(4s,5r)-5-(hydroxymethyl)-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxolan-2-one
(1s,8r,10r,11r)-1,6,11-trihydroxy-4-imino-10-methyl-3-oxo-9-oxatricyclo[6.2.2.0²,⁷]dodeca-2(7),5-diene-5-carboximidic acid
(7s)-7-hydroxy-1-methyl-6-methylidene-7h,8h,9h-phenanthro[1,2-b]furan-10,11-dione
(2e)-3-phenylprop-2-enoyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
4-amino-1,11-dihydroxy-10-methyl-3,6-dioxo-9-oxatricyclo[6.2.2.0²,⁷]dodeca-2(7),4-diene-5-carboximidic acid
3-hydroxy-1-(4-methoxy-1-benzofuran-5-yl)-3-phenylprop-2-en-1-one
(3s,3's)-2-hydroxy-4-methyl-3'-phenylspiro[1,4-benzodiazepine-3,2'-oxiran]-5-one
C17H14N2O3 (294.10043740000003)
[(2r,3s,4s,5r,6r)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl (3s)-3,4-dihydroxy-2-methylidenebutanoate
4-(methylsulfanyl)-5-{pyrido[3,4-b]indol-9-ylmethyl}-3h-imidazole
2-hydroxy-4,8-dimethyl-8h,9h-phenanthro[3,2-b]furan-7,11-dione
(3,4,5,6-tetrahydroxyoxan-2-yl)methyl 3,4-dihydroxy-2-methylidenebutanoate
(2r,3r)-2,3-dihydroxy-2-phenyl-3h,5h-cyclopenta[c]isochromen-1-one
8,12-dihydroxy-7-methyl-3h,4h-phenanthro[2,1-c]pyran-1-one
4'-hydroxy-8h-spiro[acenaphthyleno[3,4-d][1,3]dioxole-1,1'-cyclohexan]-2'-en-2-one
(1r,4's)-4'-hydroxy-8h-spiro[acenaphthyleno[3,4-d][1,3]dioxole-1,1'-cyclohexan]-2'-en-2-one
5-[5-carboxy-4-(carboxymethyl)pyrrolidin-3-yl]pyridine-2-carboxylic acid
3-acetyl-2-[(4-hydroxyphenyl)methyl]quinazolin-4-one
C17H14N2O3 (294.10043740000003)
2-hydroxy-4-methyl-3'-phenylspiro[1,4-benzodiazepine-3,2'-oxiran]-5-one
C17H14N2O3 (294.10043740000003)
2-({2-[(2-carboxy-1-hydroxyethylidene)amino]-1-hydroxypropylidene}amino)benzoic acid
4,8-dimethyl-3,4-dihydro-2,12-dioxatetraphene-1,5-dione
3-[(3s,4s,5s)-5-carboxy-4-(carboxymethyl)pyrrolidin-3-yl]pyridine-2-carboxylic acid
(3'r)-2-hydroxy-4-methyl-3'-phenylspiro[1,4-benzodiazepine-3,2'-oxiran]-5-one
C17H14N2O3 (294.10043740000003)
(3r,3's)-2-hydroxy-4-methyl-3'-phenylspiro[1,4-benzodiazepine-3,2'-oxiran]-5-one
C17H14N2O3 (294.10043740000003)